Lucy A. Eddowes

699 total citations
22 papers, 471 citations indexed

About

Lucy A. Eddowes is a scholar working on Infectious Diseases, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lucy A. Eddowes has authored 22 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Hematology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lucy A. Eddowes's work include Diabetes Treatment and Management (4 papers), HIV Research and Treatment (3 papers) and Iron Metabolism and Disorders (3 papers). Lucy A. Eddowes is often cited by papers focused on Diabetes Treatment and Management (4 papers), HIV Research and Treatment (3 papers) and Iron Metabolism and Disorders (3 papers). Lucy A. Eddowes collaborates with scholars based in United Kingdom, United States and Switzerland. Lucy A. Eddowes's co-authors include Hal Drakesmith, Andrew E. Armitage, Alain Townsend, Uzi Gileadi, Natasha Spottiswoode, T. Selvakumar, Ling‐Pei Ho, Suzanne Cole, Hans Verhoef and Edwin Tijhaar and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Lucy A. Eddowes

20 papers receiving 462 citations

Peers

Lucy A. Eddowes
Tony Fulford United Kingdom
Craig Webster United Kingdom
Masood Anwar Pakistan
Malay B. Mukherjee India
Betelihem Terefe Ethiopia
Zegeye Getaneh Ethiopia
Saqib Hussain Ansari Pakistan
M A Romeo Italy
Titilola S. Akingbola Nigeria
O Mickisch Germany
Tony Fulford United Kingdom
Lucy A. Eddowes
Citations per year, relative to Lucy A. Eddowes Lucy A. Eddowes (= 1×) peers Tony Fulford

Countries citing papers authored by Lucy A. Eddowes

Since Specialization
Citations

This map shows the geographic impact of Lucy A. Eddowes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy A. Eddowes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy A. Eddowes more than expected).

Fields of papers citing papers by Lucy A. Eddowes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy A. Eddowes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy A. Eddowes. The network helps show where Lucy A. Eddowes may publish in the future.

Co-authorship network of co-authors of Lucy A. Eddowes

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy A. Eddowes. A scholar is included among the top collaborators of Lucy A. Eddowes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy A. Eddowes. Lucy A. Eddowes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eddowes, Lucy A., et al.. (2024). US cost-utility model of lenacapavir plus optimized background regimen (OBR) vs fostemsavir plus OBR and ibalizumab plus OBR for people with HIV with multidrug resistance. Journal of Managed Care & Specialty Pharmacy. 30(9). 1001–1012. 1 indexed citations
2.
Chaponda, Mas, et al.. (2023). Investigating zero transmission of HIV in the MSM population: a UK modelling case study. Archives of Public Health. 81(1). 201–201. 1 indexed citations
3.
Gibson, Scott, Lucy A. Eddowes, Mark T. Drayson, et al.. (2023). An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom. Value in Health Regional Issues. 35. 27–33.
4.
5.
Olsson, Birgitta, Mattias Rudebeck, Jean‐Baptiste Arnoux, et al.. (2022). Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index. JIMD Reports. 63(4). 361–370. 4 indexed citations
6.
Tripathy, Debu, Sara A. Hurvitz, Denise A. Yardley, et al.. (2022). Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer. Therapeutic Advances in Medical Oncology. 14. 4287493235–4287493235. 4 indexed citations
7.
Girardin, François, Chris Painter, Lucy A. Eddowes, et al.. (2021). Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy. JHEP Reports. 3(3). 100279–100279. 10 indexed citations
8.
9.
Girardin, François, Erika Castro, Francesco Negro, et al.. (2019). Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting. Clinical Infectious Diseases. 69(11). 1980–1986. 10 indexed citations
10.
Harrington-Kandt, Rachel, Elena Stylianou, Lucy A. Eddowes, et al.. (2018). Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection model. PLoS ONE. 13(1). e0191038–e0191038. 15 indexed citations
11.
12.
Eddowes, Lucy A., et al.. (2018). Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features. JIMD Reports. 41. 53–62. 8 indexed citations
13.
14.
Leonard, S.A., et al.. (2015). Recommendations for the Improved Effectiveness and Reporting of Telemedicine Programs in Developing Countries: Results of a Systematic Literature Review. Telemedicine Journal and e-Health. 21(11). 903–915. 31 indexed citations
15.
16.
Stewart, Gavin, et al.. (2014). The Impact Of Nice’s End-Of-Life Threshold On Patient Access To New Cancer Therapies In England And Wales. Value in Health. 17(3). A6–A6. 13 indexed citations
17.
18.
Pasricha, Sant‐Rayn, Sarah H. Atkinson, Andrew E. Armitage, et al.. (2014). Expression of the Iron Hormone Hepcidin Distinguishes Different Types of Anemia in African Children. Science Translational Medicine. 6(235). 235re3–235re3. 79 indexed citations
19.
Charokopou, M., Lucy A. Eddowes, Mark D. Griffiths, et al.. (2014). Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective. Value in Health. 17(7). A347–A347. 1 indexed citations
20.
Armitage, Andrew E., Lucy A. Eddowes, Uzi Gileadi, et al.. (2011). Hepcidin regulation by innate immune and infectious stimuli. Blood. 118(15). 4129–4139. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tony Fulford Breakdown of academic impact, for papers by Craig Webster Breakdown of academic impact, for papers by Masood Anwar Breakdown of academic impact, for papers by Malay B. Mukherjee Breakdown of academic impact, for papers by Betelihem Terefe Breakdown of academic impact, for papers by Zegeye Getaneh Breakdown of academic impact, for papers by Saqib Hussain Ansari Breakdown of academic impact, for papers by M A Romeo Breakdown of academic impact, for papers by Titilola S. Akingbola Breakdown of academic impact, for papers by O Mickisch
Rankless by CCL
2026